|
業務類別
|
Medical Devices |
|
業務概覽
|
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THVis a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States. |
| 公司地址
| 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066 |
| 電話號碼
| +61 731523200 |
| 傳真號碼
| +61 1300972437 |
| 公司網頁
| https://www.anteristech.com |
| 員工數量
| 174 |
| Mr. Wayne G. Paterson |
Vice Chairman of the Board and Chief Executive Officer |
美元 696.39K |
26/02/2026 |
| Mr. Matthew McDonnell |
Chief Financial Officer and and Principal Accounting Officer |
美元 267.43K |
26/02/2026 |
| Mr. David St Denis |
President and Director |
美元 450.00K |
26/02/2026 |
|
|
| Mr. John D. Seaberg |
Chairman of the Board |
26/02/2026 |
| Dr. Wenyi Gu |
Independent Director |
09/06/2025 |
| Mr. Wayne G. Paterson |
Vice Chairman of the Board and Chief Executive Officer |
26/02/2026 |
| Mr. David B. Roberts |
Independent Director |
26/02/2026 |
| Mr. David Roberts |
Director |
09/06/2025 |
| Mr. Gregory Moss |
Independent Director |
26/02/2026 |
| Mr. David St Denis |
President and Director |
26/02/2026 |
|
|
|
|
